- Home
- TEAD vs QTRX Comparison
TEAD vs QTRX Comparison
Compare TEAD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEAD
- QTRX
- Stock Information
- Founded
- TEAD 2006
- QTRX 2007
- Country
- TEAD United States
- QTRX United States
- Employees
- TEAD N/A
- QTRX N/A
- Industry
- TEAD
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- TEAD
- QTRX Industrials
- Exchange
- TEAD NYSE
- QTRX Nasdaq
- Market Cap
- TEAD 245.2M
- QTRX 233.5M
- IPO Year
- TEAD N/A
- QTRX 2017
- Fundamental
- Price
- TEAD $2.38
- QTRX $6.20
- Analyst Decision
- TEAD
- QTRX Buy
- Analyst Count
- TEAD 0
- QTRX 5
- Target Price
- TEAD N/A
- QTRX $15.60
- AVG Volume (30 Days)
- TEAD 404.3K
- QTRX 858.3K
- Earning Date
- TEAD 08-16-2025
- QTRX 08-07-2025
- Dividend Yield
- TEAD N/A
- QTRX N/A
- EPS Growth
- TEAD N/A
- QTRX N/A
- EPS
- TEAD N/A
- QTRX N/A
- Revenue
- TEAD $959,268,000.00
- QTRX $135,688,000.00
- Revenue This Year
- TEAD $65.64
- QTRX N/A
- Revenue Next Year
- TEAD $5.29
- QTRX $14.49
- P/E Ratio
- TEAD N/A
- QTRX N/A
- Revenue Growth
- TEAD 4.15
- QTRX 7.71
- 52 Week Low
- TEAD $2.34
- QTRX $4.05
- 52 Week High
- TEAD $7.87
- QTRX $16.74
- Technical
- Relative Strength Index (RSI)
- TEAD N/A
- QTRX 55.77
- Support Level
- TEAD N/A
- QTRX $5.62
- Resistance Level
- TEAD N/A
- QTRX $6.58
- Average True Range (ATR)
- TEAD 0.00
- QTRX 0.58
- MACD
- TEAD 0.00
- QTRX 0.03
- Stochastic Oscillator
- TEAD 0.00
- QTRX 60.29
About TEAD TEADS HLDG CO
Teads Holding Co is the omnichannel outcomes platform for the open internet, driving full-funnel results for marketers across premium media. Its Focus on meaningful business outcomes for branding and performance objectives, the combined company ensures value is driven with every media dollar by leveraging predictive AI technology to connect quality media, beautiful brand creative, and context-driven addressability and measurement.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.